Cortex Pharmaceuticals news

Cortex Pharmaceuticals Inc. (CORX) Cortex Pharmaceuticals Inc. (CORX) has received a $49,000 Phase I SBIR grant from the National Cancer Institute to discover and develop drugs that interfere with th...